Pharma Reviews: Digging Deeper | Indian Pharma tastes its own bitter medicine: Seven companies named in the US ...

May has been a sweltering summer for some big name Indian pharmaceutical companies. Two weeks ago, news broke that charges were filed by 44 ...
Read more: Digging Deeper | Indian Pharma tastes its own bitter medicine: Seven companies named in the US ...

Pharma Reviews: Bottle of Lies: What's behind the Pharmacy of the World

Millions of lives all over the world have been saved by the innovation of Indian generic pharma companies. With a majority of pills consumed around ...
Read more: Bottle of Lies: What's behind the Pharmacy of the World

Pharma Reviews: Sudarshan Pharma Industries Ltd.: The Pharma Giant in the Making Announces IPO and ...

Sudarshan Pharma is set to revolutionise the healthcare industry in India, enabling ease of access for APIs and speciality pharmaceutical products, ...
Read more: Sudarshan Pharma Industries Ltd.: The Pharma Giant in the Making Announces IPO and ...

Pharma Reviews: Purdue and Indian universities to collaborate on entrepreneurship and pharmaceutical sciences ...

Purdue has just announced a partnership with two Indian universities in the state of Andhra Pradesh -- Andhra University and Sri Venkateswara ...
Read more: Purdue and Indian universities to collaborate on entrepreneurship and pharmaceutical sciences ...

Pharma Reviews: US admits multiple molecular formulations effective in cardiovascular diseases: Industry

Ahmedabad, The Indian pharmaceutical industry has been successful in engineering multiple molecular formulations for cardiovascular and diabetic ...
Read more: US admits multiple molecular formulations effective in cardiovascular diseases: Industry

US FDA News: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions

FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions
Read more: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions

US FDA News: Statement on FDA’s request for information on requiring fixed-quantity blister packaging for certain opioid pain medicines to help decrease unnecessary exposure to opioids

FDA is soliciting feedback on the potential use of new authorities under the SUPPORT Act to require certain immediate-release opioid analgesics be made available in fixed-quantity, unit-of-use blister packaging.
Read more: Statement on FDA’s request for information on requiring fixed-quantity blister packaging for certain opioid pain medicines to help decrease unnecessary exposure to opioids

Pharma Reviews: Digging Deeper | Love for money and other drugs: How seven Indian pharma companies got ...

Seven Indian pharma companies, including Taro Pharmaceutical Industries (a subsidiary of Sun Pharma), Glenmark, Dr Reddy's and Aurobindo ...
Read more: Digging Deeper | Love for money and other drugs: How seven Indian pharma companies got ...

Pharma Reviews: AstraZeneca opens office in Bengaluru to support expansion of its clinical research footprint in India

AstraZeneca is among the top 3 initiators of clinical studies among foreign pharmaceutical companies in India in the past three years, according to ...
Read more: AstraZeneca opens office in Bengaluru to support expansion of its clinical research footprint in India

Pharma Reviews: E-commerce success: After mobile phones, clothes, now online medicine market to grow multifold

The Indian pharmaceutical market caters to two market needs — Chronic and Acute. The domestic pharma is led by the demand for acute medicines ...
Read more: E-commerce success: After mobile phones, clothes, now online medicine market to grow multifold

Pharma Reviews: Five ways pharmaceutical and healthcare sectors can be 'Modified'

India spends 1.15 per cent of its GDP on healthcare and the government has ... While the US drug regulator pulls up Indian pharma companies for ...
Read more: Five ways pharmaceutical and healthcare sectors can be 'Modified'

Pharma Reviews: Bizmen pin hopes on pharma expo to boost exports from Gujarat

India is the third largest exporter of pharmaceutical products in terms of volumes. Country's pharmaceutical production in 2018-19 stood at USD 39 ...
Read more: Bizmen pin hopes on pharma expo to boost exports from Gujarat

Pharma Reviews: Cadila Healthcare arm recalls hypertension drug in US

The ongoing recalls by the Indian pharma companies in the US are happening in the midst of a book published on how generic drugs are poisoning ...
Read more: Cadila Healthcare arm recalls hypertension drug in US

Pharma Reviews: Decline in Foreign Direct Investment inflow: Stressed telecom, uncertainty in pharma to blame

However, during 2019-20 the revenues of the Indian telecom sector are still expected to be lower than its peak of 2015-16. Drop in pharma FDI.
Read more: Decline in Foreign Direct Investment inflow: Stressed telecom, uncertainty in pharma to blame

Pharma Reviews: US admits multiple molecular formulations effective in cardiovascular diseases: Industry

The Indian pharmaceutical industry has been successful in engineering multiple molecular formulations for cardiovascular and diabetic treatment, ...
Read more: US admits multiple molecular formulations effective in cardiovascular diseases: Industry

Pharma Reviews: How ethical dilemmas tailed Sun Pharma's rise

No single form of growth-driving pharma marketing in India's generic drug space of the 1990s could be totally free from controversy. Marketing ...
Read more: How ethical dilemmas tailed Sun Pharma's rise

Pharma Reviews: The Conflict between Generic vs. Branded Medicines in India

India's Pharma industry has been in news in the West because of its exceptional growth due to exports but the domestic market and the status of the ...
Read more: The Conflict between Generic vs. Branded Medicines in India

Pharma Reviews: Addressable market for e-pharmacies in India to reach USD 18.1 billion by 2023

The key growth drivers for the e-pharma market in India are increasing internet penetration and smartphone ownership along with the ease of ordering ...
Read more: Addressable market for e-pharmacies in India to reach USD 18.1 billion by 2023

Pharma Reviews: Addressable market for e-pharmacies in India to reach $18.1 bn by 2023: EY

The key growth drivers for e-pharma market in India are increasing internet penetration and smartphone ownership along with the ease of ordering ...
Read more: Addressable market for e-pharmacies in India to reach $18.1 bn by 2023: EY

Pharma Reviews: Indian e-pharma market poised to touch US$2.7 billion by 2023: EY

India, 29 May, 2019: According to a new EY report 'e-pharma: delivering healthier outcomes', e-pharma players are expected to attain a combined ...
Read more: Indian e-pharma market poised to touch US$2.7 billion by 2023: EY

Pharma Reviews: Online-pharma market to touch $2.7 bn by 2023: Report

The key growth drivers for e-pharma market according to the report is the ... and National Leader – E-Commerce and Consumer Internet at EY India.
Read more: Online-pharma market to touch $2.7 bn by 2023: Report

Pharma Reviews: Pharma sector hopes Modi 2.0 will start reforms

HYDERABAD: The Indian pharmaceutical industry, which is battling a host of challenges, including scrutiny by the US FDA, litigation on alleged drug ...
Read more: Pharma sector hopes Modi 2.0 will start reforms

Pharma Reviews: Sun Pharma Q4 profit halves to Rs 636 cr on distribution strategy change

Sun Pharma Founder and Managing Director Dilip Shanghvi said the ... For Q4FY19, the company launched 12 new products in the Indian market.
Read more: Sun Pharma Q4 profit halves to Rs 636 cr on distribution strategy change

Pharma Reviews: Sun Pharma net profit rises 27.2% to Rs 2665.42 crore in FY19; revenue up 10%

Sun Pharma holds approximately 8.2 per cent market share in the over Rs 131,000 crore Indian pharmaceutical market as per AIOCD AWACS ...
Read more: Sun Pharma net profit rises 27.2% to Rs 2665.42 crore in FY19; revenue up 10%

Pharma Reviews: Sun Pharma Q4 profit declines 53% to Rs 635.9 crore due to one-time charge

India's largest drugmaker Sun Pharmaceutical Industries reported a 53 percent year-on-year (YoY) drop in net profit to Rs 635.9 crore in the fourth ...
Read more: Sun Pharma Q4 profit declines 53% to Rs 635.9 crore due to one-time charge

Pharma Reviews: A Look At Generic Pharma's Dark Underbelly

While the title reflects the main theme of the book, Bottle of Lies does not ignore or even trivialise the role of Indian generic pharma companies in ...
Read more: A Look At Generic Pharma's Dark Underbelly

Pharma Reviews: Top 5 challenges faced by data analytics startups

Any leader in the Indian Pharma industry in India is currently at an interesting stage of transition from “traditional” to “new-age”, in order to address a ...
Read more: Top 5 challenges faced by data analytics startups

Pharma Reviews: How Many Pills Do U Pop In Daily?

The global giant in the pharma sector Pfizer may see an extraordinary ... Where is our Indian pharma industry which boasts of exports of $ 40 billion ...
Read more: How Many Pills Do U Pop In Daily?

Pharma Reviews: India, China foreign ministers to prepare ground for Modi-XI informal summit to be held this year

In this connection, Vimal pointed out that Indian pharma companies were concentrating on European markets and have a limited presence in China.
Read more: India, China foreign ministers to prepare ground for Modi-XI informal summit to be held this year

Pharma Reviews: Karnataka gets 1040 pharma seats in 16 new colleges

BENGALURU: The All India Council for Technical Education (AICTE) ... There are abundant opportunities in pharmaceutical research and marketing.
Read more: Karnataka gets 1040 pharma seats in 16 new colleges

Pharma Reviews: Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

He says growth in the Indian generics business, a push into China, and ... The two branded medicines the Israel-based firm had been counting on to ...
Read more: Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

Pharma Reviews: India should cut interest rates to help exporters take advantage of US-China trade war: Ficci chief

On India's demand for China to open its pharma sector, Somany said Indian pharma companies feel the Chinese market is not an easy place to invest ...
Read more: India should cut interest rates to help exporters take advantage of US-China trade war: Ficci chief

Pharma Reviews: AICTE approves additional 57 k pharma seats in 448 new colleges

There are abundant opportunities in pharmacy research and marketing ... "I think there will be a very huge demand and India can actually provide a lot ...
Read more: AICTE approves additional 57 k pharma seats in 448 new colleges

Pharma Reviews: Industry's reactions to the New Government

"India's healthcare sector has witnessed some landmark developments in ... and to become the next big Brand India success story after IT & Pharma.
Read more: Industry's reactions to the New Government

Pharma Reviews: Safeguarding India's health

Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD) said “The last five years witnessed significant developments in ...
Read more: Safeguarding India's health

US FDA News: FDA approves first PI3K inhibitor for breast cancer

FDA approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant.
Read more: FDA approves first PI3K inhibitor for breast cancer

US FDA News: FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality
Read more: FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

US FDA News: test article-524-FT

test article-524-DD
Read more: test article-524-FT

Pharma Reviews: Expect cheap blood tests & drugs within first 100 days of Modi 2.0

The proposal has been drafted by the Bureau of Pharma PSUs of India ... The government is also likely to announce the development of industry parks ...
Read more: Expect cheap blood tests & drugs within first 100 days of Modi 2.0

Pharma Reviews: Looking beyond generic, Sun Pharma plans to develop its own medicines

“I don't have any data on any company, be it Indian or non-Indian generic majors, who have made an impact out of launching or selling new drugs.”.
Read more: Looking beyond generic, Sun Pharma plans to develop its own medicines

US FDA News: FDA permits marketing of first diagnostic test to aid in detecting prosthetic joint infections

FDA permits marketing of first diagnostic test to aid in detecting prosthetic joint infections
Read more: FDA permits marketing of first diagnostic test to aid in detecting prosthetic joint infections

US FDA News: FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies

FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies
Read more: FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies

US FDA News: FDA alerts hospitals, laboratories and health care professionals about recall of Beckman Coulter blood test analyzers due to risk of inaccurate platelet analyzing results

FDA alerts hospitals, laboratories and health care professionals about recall of Beckman Coulter blood test analyzers due to risk of inaccurate platelet analyzing results
Read more: FDA alerts hospitals, laboratories and health care professionals about recall of Beckman Coulter blood test analyzers due to risk of inaccurate platelet analyzing results

US FDA News: FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea

FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea
Read more: FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea

Pharma Reviews: Election Result 2019: Why Modi 2.0 will make India a stronger military power

The result was that India's strategic aims were stunted and the armed forces ... Also Read:What Modi 2.0 could mean for the Indian pharma industry?
Read more: Election Result 2019: Why Modi 2.0 will make India a stronger military power

Pharma Reviews: What Modi 2.0 could mean for the Indian pharma industry?

The Rs 1,20,000 crore plus Indian pharma industry has been through a churn in the past five years. Over the last year, it has finally seen double-digit ...
Read more: What Modi 2.0 could mean for the Indian pharma industry?

Pharma Reviews: Investors find new formula in pharma as focus shifts from US generics

When American pharmaceutical makers got hit last week by accusations of collusion and price fixing, the tremors were felt by their peers in India.
Read more: Investors find new formula in pharma as focus shifts from US generics

Pharma Reviews: What if Amazon takes over Flipkart? India's antitrust watchdog starts study

India's antitrust watchdog is assessing the domestic e-commerce sector, a step ... This impact on Indian pharma — specifically the listed ones, with …
Read more: What if Amazon takes over Flipkart? India's antitrust watchdog starts study

US FDA News: Federal judge enters consent decree against compounder PharMedium Services for violations at multiple facilities

U.S. District Judge Virginia M. Kendall for the Northern District of Illinois entered a consent decree of permanent injunction today between the United States and PharMedium Services, LLC, headquartered in Lake Forest, Illinois.
Read more: Federal judge enters consent decree against compounder PharMedium Services for violations at multiple facilities

Pharma Reviews: Cipla finally delivers growth in the March quarter, all eyes on FY20 now

In India, it expects to grow faster than the 8-10% market growth. ... The last two years have been difficult for Indian pharma due to changes in tax policy ...
Read more: Cipla finally delivers growth in the March quarter, all eyes on FY20 now

US FDA News: Federal court enters consent decree against Texas compounder, Pharm D Solutions, LLC to cease the manufacturing of drugs intended to be sterile due to insanitary conditions

A federal court ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Read more: Federal court enters consent decree against Texas compounder, Pharm D Solutions, LLC to cease the manufacturing of drugs intended to be sterile due to insanitary conditions

Pharma Reviews: Lupin launches asthma drug in the US

Budesonide Inhalation Suspension ampules are a generic equivalent of Pulmicort Respules Inhalation Suspension drugs of UK-based pharma firm ...
Read more: Lupin launches asthma drug in the US

Pharma Reviews: India's Biggest Drugmaker Plans to Start Developing Its Own Medicines

After a four-year decline that erased 65% from the value of Sun Pharmaceutical Industries Ltd., the drugmaker he founded, Shanghvi is preparing to ...
Read more: India's Biggest Drugmaker Plans to Start Developing Its Own Medicines

Pharma Reviews: Is China The New Frontier For Indian Generics?

China, the world's second-largest pharma market, is expected to be the next growth driver for Indian drugmakers amid a slowdown in the U.S..
Read more: Is China The New Frontier For Indian Generics?

Pharma Reviews: Why investors should be more worried about Lupin than DRL

Muted fourth-quarter performance saw stocks of the pharma majors Dr ... Its acquisition of Gavis — the largest buyout by an Indian pharma company ...
Read more: Why investors should be more worried about Lupin than DRL

Pharma Reviews: Aushidhi for the Underprivileged

Aushidhi collects medicines from Donor, who mostly is the Pharmaceuticals Company / Pharmacy / Doctor/Any Indian Citizen having an excess of ...
Read more: Aushidhi for the Underprivileged

Pharma Reviews: “The Golden Days Are Here Again” –Clinical Trial Market of India in 2019 and onwards

Besides the above change, the drug companies considering India as a market for running local clinical trials get additional benefits if the drugs are ...
Read more: “The Golden Days Are Here Again” –Clinical Trial Market of India in 2019 and onwards

Pharma Reviews: Collusion over drug prices: Will generic manufacturers pay?

Also read: Indian pharma companies feel the heat of price-fixing charges by US govt: All you need to know. Other companies named in the complaint ...
Read more: Collusion over drug prices: Will generic manufacturers pay?

US FDA News: Statement from Jeff Shuren, M.D., director of the Center for Devices and Radiological Health, on agency efforts to mitigate temporary shortage of pediatric breathing tubes due to recent closure of Illinois sterilization facility

FDA efforts to mitigate temporary shortage of pediatric breathing tubes due to recent closure of Illinois sterilization facility
Read more: Statement from Jeff Shuren, M.D., director of the Center for Devices and Radiological Health, on agency efforts to mitigate temporary shortage of pediatric breathing tubes due to recent closure of Illinois sterilization facility

Pharma Reviews: The man who brought Ranbaxy to its knees is pushing for 'Made in India' tag on drugs sold in US

These are not the best of times for Indian pharma companies. Recently, a US lawsuit alleged that Sun Pharma's Taro amongst other generic drug ...
Read more: The man who brought Ranbaxy to its knees is pushing for 'Made in India' tag on drugs sold in US

Pharma Reviews: Indian pharma industry unfairly targeted in the book “Bottle of Lies” : Pharmexcil

Hyderabad: Pharmaceuticals Export Promotion Council of India (Pharmexcil) has raised objections over the book written by a former US FDA auditor ...
Read more: Indian pharma industry unfairly targeted in the book “Bottle of Lies” : Pharmexcil

Pharma Reviews: New high-tech laboratory at IICT in Hyderabad

... Rao, the former Director of IICT, who has developed over 50 drug technologies that have been commercialised by the Indian pharma industry.
Read more: New high-tech laboratory at IICT in Hyderabad

US FDA News: FDA Warns Against the Use of Unauthorized Devices for Diabetes Management

FDA Warns Against the Use of Unauthorized Devices for Diabetes Management
Read more: FDA Warns Against the Use of Unauthorized Devices for Diabetes Management

Pharma Reviews: Prescription for a healthy career

Indian pharmaceutical companies supply more than 50% of the global demand for various vaccines as well as a significant amount of generic drugs.
Read more: Prescription for a healthy career

Pharma Reviews: Need a new brand name if composition of drug is changed: Pharma regulator

India's apex drug regulatory body has asked its officials to take “all measures” to prevent companies from retaining the same brand name for different ...
Read more: Need a new brand name if composition of drug is changed: Pharma regulator

US FDA News: FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots

The FDA approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients one month of age and older.
Read more: FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots

US FDA News: E-cigarette: Safety Communication - Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults

Safety Communication - Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults
Read more: E-cigarette: Safety Communication - Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults

Pharma Reviews: Can Indian pharma weather the twin-storm in US of price-fixing and quality?

Leading Indian generic pharma companies have come under the spotlight in the United States. This time for all the wrong reasons. They figure among ...
Read more: Can Indian pharma weather the twin-storm in US of price-fixing and quality?

Pharma Reviews: Share Market Live: Sensex up 45 points, Nifty at 11184; Tata Global, Tata Chemical top gainers

Indian shares were little changed in light trade on Thursday, with losses in pharmaceutical stocks offsetting gains in IT counters, as investors stuck to ...
Read more: Share Market Live: Sensex up 45 points, Nifty at 11184; Tata Global, Tata Chemical top gainers

Pharma Reviews: New book warns Americans against 'flea-market quality' Indian generic drugs

New Delhi: A new book is warning India's biggest pharmaceutical export market — the US — against consuming the country's generic drugs, arguing ...
Read more: New book warns Americans against 'flea-market quality' Indian generic drugs

Pharma Reviews: Indian Pharma's incentives to do business in US on steady decline

When Sun Pharma chief Dilip Shanghvi says he sees a big opportunity in China, the world's second-largest drug market, it may be indicative of the ...
Read more: Indian Pharma's incentives to do business in US on steady decline

Pharma Reviews: Price-fixing suit puts Big Pharma under spotlight

... companies named in the complaint, seven are Indian—Aurobindo Pharma Ltd, ... The complaint is backed by an industry-wide phone call database ...
Read more: Price-fixing suit puts Big Pharma under spotlight

Pharma Reviews: Ex-FDA chief Scott Gottlieb endorses use of generic drugs

MUMBAI: The US generic drug industry, dominated by Indian companies, has found a surprising champion in former US Food and Drug ...
Read more: Ex-FDA chief Scott Gottlieb endorses use of generic drugs

Pharma Reviews: Indian pharma companies feel the heat of price-fixing charges by US govt: All you need to know

Of the 20 major pharmaceutical firms named in a recent antitrust lawsuit filed by 44 American states, seven of them are Indian. Sun Pharma's US arm, ...
Read more: Indian pharma companies feel the heat of price-fixing charges by US govt: All you need to know

US FDA News: test article-5/9-FT-Medwatch RSS Feed

test article-5/9-FT-Medwatch RSS Feed
Read more: test article-5/9-FT-Medwatch RSS Feed

Pharma Reviews: 7 Indian pharma companies named in US lawsuit over inflating generic drug prices

The Indian companies named in the lawsuit are Sun Pharma's US arm Taro, Zydus, Lupin, Aurobindo Pharma, Dr Reddy's, Wockhardt and Glenmark.
Read more: 7 Indian pharma companies named in US lawsuit over inflating generic drug prices

Pharma Reviews: Indian pharma majors deny allegations of price fixing in US

New Delhi: Indian pharma majors Dr Reddy's, Workhardt, Aurobindo and ... The companies have been accused of violating antitrust laws by fixing ...
Read more: Indian pharma majors deny allegations of price fixing in US

Pharma Reviews: 'Bottle of Lies': Book on Generic Drugs 'Exposes' Indian Companies

'Bottle of Lies' opens a can of worms for Indian drug companies. The new book by Katherine Eban, called an “invaluable exposé” by The New York ...
Read more: 'Bottle of Lies': Book on Generic Drugs 'Exposes' Indian Companies

Pharma Reviews: Opinion | Indian pharma at the crossroads as US cracks the whip

There are very few industries as notorious as Big Pharma. Fewer still have done more to deserve that notoriety. Tweaking existing drugs to generate ...
Read more: Opinion | Indian pharma at the crossroads as US cracks the whip

Pharma Reviews: A frightening new book on the safety of generic drugs could send India's pharma industry into an ...

The book is an account of the lapses in good manufacturing practices by drug exporters to US. Indian companies are big exporters of medicines to US ...
Read more: A frightening new book on the safety of generic drugs could send India's pharma industry into an ...

Pharma Reviews: Understanding the biosimilars opportunity for Indian pharma

Biologics, a category of pharmaceuticals which has been around for more than a decade, is back on discussion forums given the huge global market ...
Read more: Understanding the biosimilars opportunity for Indian pharma

Pharma Reviews: Early US probe findings may impact pharma companies

With over 40 US states filing lawsuits against seven Indian pharmaceutical companies for alleged collusion in artificially inflating drug prices and ...
Read more: Early US probe findings may impact pharma companies

Pharma Reviews: From Aurobindo to Zydus, Indian pharma majors face price-fixing heat in the US

The other companies under the scanner include Dr. Reddy's, Glenmark, Lupin, Wockhardt, and Sun Pharma's unit in the US, Taro. If found guilty, the ...
Read more: From Aurobindo to Zydus, Indian pharma majors face price-fixing heat in the US

Pharma Reviews: Opinion | An alleged drug cartel awaits trial in America

After facing American scrutiny over quality issues, India's pharmaceutical industry has again landed in the crosshairs of US regulatory action.
Read more: Opinion | An alleged drug cartel awaits trial in America

Pharma Reviews: Indian pharma majors deny allegations of price fixing in US

Indian pharma majors Dr Reddy's, Workhardt, Aurobindo and Glenmark, ... The companies have been accused of violating antitrust laws by fixing ...
Read more: Indian pharma majors deny allegations of price fixing in US

Pharma Reviews: Jet Airways CEO, CFO resign as revival hopes fade

Lenders of Jet Airways led by state-run State Bank of India (SBI) are ... Usually factories of Indian pharma companies are booked for not meeting the ...
Read more: Jet Airways CEO, CFO resign as revival hopes fade

Pharma Reviews: Antitrust case: Indian firms to defend price fixing charges in US lawsuit

In response to the allegations made in the antitrust lawsuit filed by over 40 US states against 21 pharma manufacturers, domestic generic companies ...
Read more: Antitrust case: Indian firms to defend price fixing charges in US lawsuit

Pharma Reviews: US antitrust probe singes India's pharmaceutical firms; Sun Pharma falls 9%

Share prices of some leading domestic pharmaceutical companies, led by Sun Pharmaceutical Industries, fell 4-9 per cent on Monday, after being ...
Read more: US antitrust probe singes India's pharmaceutical firms; Sun Pharma falls 9%

Pharma Reviews: Pharmaceutical duo vow to fight price fix charge

Besides DRL and Aurobindo, charges have been filed against five other Indian companies — Glenmark, Lupin, Wockhardt, Zydus and Sun Pharma's ...
Read more: Pharmaceutical duo vow to fight price fix charge

Pharma Reviews: Antitrust case: Indian pharma firms to defend price fixing charges in US lawsuit

The lawsuit is about collusion in inflating prices of widely-prescribed generic medicines and names 21 generic drug manufacturers as conspirators in ...
Read more: Antitrust case: Indian pharma firms to defend price fixing charges in US lawsuit

Pharma Reviews: Indian pharma majors deny allegations of price fixing in US

Indian pharma majors Dr Reddy's, Wockhardt, Aurobindo and Glenmark, which ... Sun Pharmaceutical Industries Limited has not been named in these ...
Read more: Indian pharma majors deny allegations of price fixing in US

Pharma Reviews: US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 million

A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian ...
Read more: US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 million

Pharma Reviews: Podcast | Editor's Pick: Uber's IPO a flop; Jet Airways empty at the top; On 4th June monsoon likely ...

Yesterday, the stocks of leading Indian pharmaceutical companies tanked, and India's largest drug maker Sun Pharma was hit the worst, with its ...
Read more: Podcast | Editor's Pick: Uber's IPO a flop; Jet Airways empty at the top; On 4th June monsoon likely ...

Pharma Reviews: 20 Indian Pharma Companies Accused of Price Fixing in US Lawsuit

New Delhi: Twenty Indian generic pharmaceutical companies have been named in an anti-trust lawsuit in the US. Some of India's most prominent drug ...
Read more: 20 Indian Pharma Companies Accused of Price Fixing in US Lawsuit

Pharma Reviews: "We are registering 20% month-on-month growth:":PradeepDadha

According to Frost & Sullivan, the e-Pharmacy market in India is estimated to grow at a CAGR of 63% to reach US $3,657 million (INR 25,000 Crores) ...
Read more: "We are registering 20% month-on-month growth:":PradeepDadha

Pharma Reviews: Reporter's Take | Anti-trust case spooks Indian generic drug companies

Stocks of Indian pharmaceutical companies tanked after the second anti-trust case against 20 pharma companies in US. This lawsuit seeks expansion ...
Read more: Reporter's Take | Anti-trust case spooks Indian generic drug companies

Pharma Reviews: Drug-makers accused of price manipulation in second antitrust lawsuit in US

On May 13, the stocks of leading Indian pharmaceutical companies tanked, and India's largest drug maker Sun Pharma was hit the worst, with its ...
Read more: Drug-makers accused of price manipulation in second antitrust lawsuit in US

Pharma Reviews: Shares of most Indian drug makers named in US lawsuit rebound today

Many Indian pharmaceutical companies named in an anti-trust lawsuit filed by 44 US states accusing them of price manipulation traded higher on ...
Read more: Shares of most Indian drug makers named in US lawsuit rebound today

Pharma Reviews: Pharma top brass discussed drug price fixing at 'industry dinners', reveal court documents

The complaint names 20 pharmaceutical companies, including seven Indian companies. The Indian firms named are Aurobindo, Dr Reddys, ...
Read more: Pharma top brass discussed drug price fixing at 'industry dinners', reveal court documents

Pharma Reviews: 7 Indian drug makers named in US lawsuit for inflating prices of generic medicines

A total of 44 US states got together on Friday to file a lawsuit against as many as 20 pharma companies, including seven Indian firms, for engaging in ...
Read more: 7 Indian drug makers named in US lawsuit for inflating prices of generic medicines

Pharma Reviews: Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices

If successfully argued, the lawsuit could result in billions of dollars worth of fines for the concerned companies. The fines for Indian pharma firms are ...
Read more: Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices

Pharma Reviews: Seven Indian Drugmakers Named In US Lawsuit For Inflating Prices Of Generics

The Nifty Pharma Index fell the most in nearly 30 months yesterday led by Sun Pharmaceutical Industries Ltd. and Cadila Healthcare Ltd. over ...
Read more: Seven Indian Drugmakers Named In US Lawsuit For Inflating Prices Of Generics

Pharma Reviews: Markets Live: Sensex down 85 points, Nifty at 11124; Jet Airways slumps 9 pc

Here's a look at live updates for the Indian share market today: ... a subsidiary of Sun Pharma, which is India's largest pharma company by sales.
Read more: Markets Live: Sensex down 85 points, Nifty at 11124; Jet Airways slumps 9 pc

Pharma Reviews: Pharma stocks crash after US lawsuit over price manipulations

ET was the first Indian paper to report on the lawsuit, its contents and ... The fresh suit names 20 pharmaceutical companies, including seven Indian ...
Read more: Pharma stocks crash after US lawsuit over price manipulations

Pharma Reviews: Stocks in the news: Nestle India, Vodafone Idea, DHFL, Polycab India and Endurance Technologies

Nestle India, Pidilite Industries: Nestle India, Endurance Technologies, ... Pharma and president of Sun Pharma in drug industry cartelisation case.
Read more: Stocks in the news: Nestle India, Vodafone Idea, DHFL, Polycab India and Endurance Technologies

Pharma Reviews: 7 Indian pharma cos face lawsuits from over 40 US states

Mumbai: More than 40 US states filed lawsuits against pharma majors, including seven domestic companies, over collusion in inflating prices of widely ...
Read more: 7 Indian pharma cos face lawsuits from over 40 US states

Pharma Reviews: US antitrust probe singes India's pharmaceutical firms; Sun Pharma falls 9%

Sun Pharma, which is India's largest pharma company by sales, is already under a cloud over corporate governance issues and is facing Sebi probe ...
Read more: US antitrust probe singes India's pharmaceutical firms; Sun Pharma falls 9%

Pharma Reviews: NBCC decides against diluting conditions in revised bid for Jaypee Tech

The Allahabad bench of National Company Law Tribunal ( NCLT) has ... Sun Pharma, which is India's largest pharma company by sales, is already ...
Read more: NBCC decides against diluting conditions in revised bid for Jaypee Tech

Pharma Reviews: Hero bets on premium 125 cc segment for scooters despite slowdown in market

“In urban areas, which are the primary market for scooters, the college ... Sun Pharma, which is India's largest pharma company by sales, is already ...
Read more: Hero bets on premium 125 cc segment for scooters despite slowdown in market

Pharma Reviews: Cotton shortage prompts spinning mills to switch to man-made fiber

Cotton Association of India (CAI), the apex industry body, has revised .... Sun Pharma, which is India's largest pharma company by sales, is already ...
Read more: Cotton shortage prompts spinning mills to switch to man-made fiber

Pharma Reviews: After staples, discretionary categories feel the pinch of slowdown

He says, “There is some disruption in the market due … ... Sun Pharma, which is India's largest pharma company by sales, is already under a cloud ...
Read more: After staples, discretionary categories feel the pinch of slowdown

Pharma Reviews: Veeba Foods forays into child nutrition space; sets up factory in Rajasthan

The company spends 10-12 per cent of its revenue in marketing and ... Sun Pharma, which is India's largest pharma company by sales, is already ...
Read more: Veeba Foods forays into child nutrition space; sets up factory in Rajasthan

Pharma Reviews: Top Indian drug makers accused of fixing prices

NEW DELHI/WASHINGTON: Seven Indian drug makers, including Sun Pharmaceutical Industries Ltd and Dr Reddy's Laboratories Ltd, and five of ...
Read more: Top Indian drug makers accused of fixing prices

Pharma Reviews: Business Top 5: HDFC MF buys 1 cr BHEL shares in Apr 19; pharma firms collude to raise prices ...

1) Pharma Lawsuits. Indian pharma companies were in focus today as 6 Indian drugmakers were named in a lawsuit filed by 44 states of the USA.
Read more: Business Top 5: HDFC MF buys 1 cr BHEL shares in Apr 19; pharma firms collude to raise prices ...

Pharma Reviews: What spooked Sun Pharma stock in Monday's trade

NEW DELHI: The pharma pack tumbled on Dalal Street on Monday on ... The names of some Indian companies in the lawsuit has spooked investors," ...
Read more: What spooked Sun Pharma stock in Monday's trade

Pharma Reviews: Addressing the supply chain problems in the healthcare industry

As the healthcare services, medicines, equipment, and other products are ... Indian pharmaceuticals market, the third-largest in terms of volume, has ...
Read more: Addressing the supply chain problems in the healthcare industry

Pharma Reviews: Congressman, industry and doctors favour accelerated traction on India-US synergies for universal ...

Council for Healthcare and Pharma (CHP) supports concerted joint action. The Council for Healthcare and Pharma hailed its recently concluded ...
Read more: Congressman, industry and doctors favour accelerated traction on India-US synergies for universal ...

Pharma Reviews: Naidu urges Vietnam to support entry of Indian pharma firms in their market

New Delhi, May 13 (KNN) The Vice President of India, M Venkaiah Naidu has urged Vietnam to support entry of Indian pharmaceutical firms. Seeking ...
Read more: Naidu urges Vietnam to support entry of Indian pharma firms in their market

Pharma Reviews: Public Policy Push for Ayurveda

The reference for this drug is given in Rasendra Sara Sangraha Krimi Chikitsa ... The Western pharma industry keeps up a well-orchestrated tirade against ... India has been struggling with nutritional anaemia in spite of crores being ...
Read more: Public Policy Push for Ayurveda

Pharma Reviews: Workshop on updating, restructuring course curriculum for Master Degree Programme begins

He emphasized upon the phenomenal growth of Indian Pharma Industry and also told that where India in the Pharmaceutical Industries stand today?
Read more: Workshop on updating, restructuring course curriculum for Master Degree Programme begins

Pharma Reviews: Naidu seeks Indian pharma's entry into Vietnam

Naidu seeks Indian pharma's entry into Vietnam ... in facilitating entry of Indian pharmaceutical products into Vietnam and offered Indian assistance in ...
Read more: Naidu seeks Indian pharma's entry into Vietnam

Pharma Reviews: Conducting Programmes by Pharma Companies for Brand Promotion Expenses is Business ...

Conducting Programmes by Pharma Companies for Brand Promotion ... the provisions contained under Indian Medical Council (Professional Conduct ...
Read more: Conducting Programmes by Pharma Companies for Brand Promotion Expenses is Business ...

Pharma Reviews: Summit by US Pharma Firms: Health Ministry Officials' Participation Raises Eyebrows

His report also cited Indian price controls on medical devices and pharmaceuticals as 'obstacles' for US companies. It is important to note that the ...
Read more: Summit by US Pharma Firms: Health Ministry Officials' Participation Raises Eyebrows

Pharma Reviews: Pharma companies guilty of overcharging to get one-time interest waiver of Rs 1325 crore

The department made the offer in two letters dated March 13 and April 2, that was sent out to pharma lobby groups including Indian Pharmaceutical ...
Read more: Pharma companies guilty of overcharging to get one-time interest waiver of Rs 1325 crore

Pharma Reviews: Govt offers pharma industry one-time waiver of Rs 1325.5 cr in overcharging case

Out of this amount, it is proposed to condone interest of Rs 1,325.5 crore," the government said in letters written to industry associations Indian Drug ...
Read more: Govt offers pharma industry one-time waiver of Rs 1325.5 cr in overcharging case

Pharma Reviews: Broker Radar for May 8

HSBC on Alembic Pharma maintains 'Hold'; cut TP to Rs 575 from Rs 600. ... India's branded generics market undergoing deep transformation. Indian ...
Read more: Broker Radar for May 8

Pharma Reviews: Government offers drug firms ₹3501 crore settlement for price cap penalties

To settle such disputes, DoP has written letters dated 13 March and 2 April to pharma lobby groups including Indian Pharmaceutical Alliance (IPA) and ...
Read more: Government offers drug firms ₹3501 crore settlement for price cap penalties

Pharma Reviews: Health min officials attending pharma lobby 'summit' raises eyebrows

Health min officials attending pharma lobby 'summit' raises eyebrows ... influence from pharmaceutical transnational corporations on India's policy ...
Read more: Health min officials attending pharma lobby 'summit' raises eyebrows

Pharma Reviews: Indian paper industry growing at 7%: IPMA

According to a report released by Indian Paper Manufacturers Association (IPMA) ... The report said the paper industry has the market size of more than ... organised retail, growth in eCommerce, FMCG, pharma/ healthcare sector, ...
Read more: Indian paper industry growing at 7%: IPMA

Pharma Reviews: US disruption may have singed Indian pharma but it is emerging stronger

An analysis of pharmaceutical sales trends in the US by Nomura Financial Advisory and Securities (India) Pvt. Ltd shows Indian companies are ...
Read more: US disruption may have singed Indian pharma but it is emerging stronger

Pharma Reviews: Ex MSCI India head joins ESG fund set up by former Tata executives

Ex MSCI India head joins ESG fund set up by former Tata executives ..... According to data released by the Pharmaceutical Exports Promotion Council ...
Read more: Ex MSCI India head joins ESG fund set up by former Tata executives

Pharma Reviews: Bulk drug exports rise as Indian makers cash in on China's regulatory woes

Around September last year, the Indian pharmaceutical industry had warned that as sourcing of APIs had become a challenge, pipeline stock was ...
Read more: Bulk drug exports rise as Indian makers cash in on China's regulatory woes

Product Recall Alerts: Vivimed Recalls 19 Lots of Blood Pressure Medication for a Potential Cancer Risk

In just over two weeks, this is the fourth time a recall alert has been made for blood pressure medication that could increase the risk of cancer on using ...
Read more: Vivimed Recalls 19 Lots of Blood Pressure Medication for a Potential Cancer Risk

Pharma Reviews: Sun Pharmaceutical eyes Chinese market

The $160-billion Chinese drug market is now a focus for Indian generics as US-approved drugs are cleared faster, Jefferies analyst Piyush Nahar ...
Read more: Sun Pharmaceutical eyes Chinese market

Pharma Reviews: China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers ...
Read more: China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

Pharma Reviews: China is a 'big opportunity' for Sun Pharma, says founder Dilip Shanghvi

With a recovery underway in its US business, Sun Pharma's billionaire ... The $160 billion Chinese drug market “is now a focus for Indian generics" as ...
Read more: China is a 'big opportunity' for Sun Pharma, says founder Dilip Shanghvi

Pharma Reviews: China's war on healthcare costs lures India's top drugmaker Sun Pharma

While Sun Pharma's Indian rivals, like Dr. Reddy's Laboratories Ltd. and ... The $160 billion Chinese drug market “is now a focus for Indian generics” ...
Read more: China's war on healthcare costs lures India's top drugmaker Sun Pharma

Pharma Reviews: Sun Pharmaceuticals to set up an ethics committee to oversee corporate governance-related matters

Sun Pharma has lost nearly $1 billion in valuation in the last six months ... This alleged that subsidiary Aditya Medisales had lent to companies run by ... Sun is one of the names that has featured along with other Indian pharma firms.
Read more: Sun Pharmaceuticals to set up an ethics committee to oversee corporate governance-related matters

Pharma Reviews: Desi pharma bags 9% more USFDA nods

The US generics market, a key driver of Indian pharma's growth, has always been a dynamic market. But the pace of change has accelerated in the ...
Read more: Desi pharma bags 9% more USFDA nods

Pharma Reviews: China's war on healthcare costs lures India's biggest drugmaker

The $160 billion Chinese drug market “is now a focus for Indian generics” as U.S.-approved drugs are cleared faster, Jefferies analyst Piyush Nahar ...
Read more: China's war on healthcare costs lures India's biggest drugmaker

Pharma Reviews: India's biggest drugmaker lured by China's war on healthcare

Sun Pharmaceutical Industries Ltd. is scouting for a partner in China to help it win a larger piece of the world's second-largest drug market, where the ...
Read more: India's biggest drugmaker lured by China's war on healthcare

Pharma Reviews: Cipla is undergoing a big transformation and is doing something it once eschewed

The league table of Indian pharma companies is led by Sun Pharma, which currently enjoys a market cap a shade above Rs 1 trillion. Then come Dr ...
Read more: Cipla is undergoing a big transformation and is doing something it once eschewed

Pharma Reviews: Congressman, Industry and Doctors Favour Accelerated Traction on India-USA Synergies for ...

The Indian Ambassador to USA, H.E. Harsh Vardhan Shringla, hailed the contribution of the Indian Generics industry in its drive towards affordable ...
Read more: Congressman, Industry and Doctors Favour Accelerated Traction on India-USA Synergies for ...

Pharma Reviews: Indian-American pharma executive convicted of opioid racketeering

WASHINGTON: An Amritsar-born Indian-American pharma billionaire has been ... They then lied to insurance companies to ensure that the expensive ...
Read more: Indian-American pharma executive convicted of opioid racketeering

US FDA News: Certain Prescription Insomnia Medicines: New Boxed Warning - Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake

MedWatch Alert on certain prescription insomnia medicines.
Read more: Certain Prescription Insomnia Medicines: New Boxed Warning - Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake

Pharma Reviews: Serdia is committed to launch new drugs in diabetes and cardiology : Dr. Georges Jabre

Serdia Pharmaceuticals is the subsidiary in India for the French pharma company called Les Laboratoires Servier. Serdia Pharmaceuticals launched ...
Read more: Serdia is committed to launch new drugs in diabetes and cardiology : Dr. Georges Jabre